Establishment and Evaluation of a New Chemiluminescent Enzyme Immunoassay for Carcinoembryonic Antigen Adapted to the Fully Automated ACCESS® System

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 10, 1996, Pages 829-836

  Matsushita, Hirotoshi ^a   Jingzhi, Xit ^a   Kondo, Akira ^a   Inoue, Emiko ^a   Teramura, Yasuo ^a   Nozawa, Masayuki ^a   Kuroki, Masahide ^b   Senba, Tarumi ^b   Yamamoto, Takafium ^b   Matsuoka, Yuji ^b  

^a DAIICHI PURE CHEMICALS CO LTD   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CARCINOEMBRYONIC ANTIGEN; HEMOGLOBIN; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY; RHEUMATOID FACTOR; TRIACYLGLYCEROL;

ACCURACY; ARTICLE; AUTOMATION; CALIBRATION; CANCER; CHEMOLUMINESCENCE; CONTROLLED STUDY; DILUTION; ENZYME BINDING; ENZYME IMMUNOASSAY; HUMAN; PRIORITY JOURNAL;

CARCINOEMBRYONIC ANTIGEN; CHEMILUMINESCENT MEASUREMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOENZYME TECHNIQUES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 0029845149     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.10.829     Document Type: Article

References (34)

1. Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344-366.
2. Goldenberg DM. Carcinoembryonic antigen: its role as a marker in the management of cancer. Br Med J 1981; 282: 373-375.
3. Klee GG, Dodge LA, Reynoso G. Discrepancies in carcinoembryonic antigen measurements: survey and control values vs values for patients. Clin Chem 1987; 33: 563-566.
4. Pilo A, Zuchelli GC, Chiesa MR, Masini S, Ferdeghini M. Anomalous betweenlaboratory variability in a collaborative study of carcinoembryonic antigen immunoassay. Clin Chem 1987; 33: 1694-695.
5. Kuroki M, Haruno M, Arakawa F, Wakisaka M, Matsuoka Y. Reaction profiles of seven enzyme immunoassay kits for carcinoembryonic antigen (CEA) analyzed with purified preparations of CEA and related normal antigens. Clin Biochem 1992; 25: 29-35.
6. Yamashita K, Totani K, Kuroki M, Matsuoka Y, Ueda I, Kobata A. Structural studies of the carbohydrate moieties of carcinoembryonic antigens. Cancer Res 1987; 47: 3451-459.
7. Miura M, Fukuyama Y, Hirano T, Hirano M, Matsuzaki H, Oka H. Sugarchain multiformity of human carcinoembryonic antigen: difference between normal and tumorassociated subfractions. Clin Chem 1990; 35: 583-584.
8. Matsunaga A, Kuroki M, Higuchi H, Arakawa F, Takakura K, Okamoto N, Matsuoka Y. Antigenic heterogeneity of carcinoembryonic antigen (CEA) in the circulation defined by monoclonal antibodies against the carbohydrate moiety of CEA and closely related antigens. Cancer Res 1987; 47: 56-61.
9. Kuroki M, Koga Y, Matsuoka Y. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody spe cificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen. J Immunol 1984; 133: 2090-097.
10. Kuroki M, Arakawa F, Higuchi H, Matsunaga A, Okamoto N, Takakura K, Matsuoka Y. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system. Jpn J Cancer Res 1987; 78: 386-396.
11. Ikeda S, Kuroki M, Haruno M, Oikawa S, Nakazato H, Kosaki G, Matsuoka Y. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies. Mol Immunol 1992; 29: 229-240.
12. Kuroki M, Arakawa F, Haruno M, Murakami M, Wakisaka M, Higuchi H, et al. Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule. Hybridoma 1992; 11: 391-407.
13. Kuroki M, Murakami M, Wakisaka M, KropWatork A, Oikawa S, Nakazato H, et al. Epitopes predominantly retained on the carcinoembryonic antigen molecules in plasma of patients with malignant lumors but not on those in plasma of normal individuals. Jpn J Cancer Res 1992; 83: 505-514.
14. Matsuoka Y, Kuroki M, Okamoto N, ikeda S, Hara Y, Minamizawa T, et al. Evaluation of a new monoclonal radioimmunoassay system for carcinoembryonic antigen. Jpn J Clin Oncol 1988; 18: 97-103.
15. Nagasaki H, Watanabe S, Kuroki M, Matsumoto Y, Murakami M, Omoda N, et al. An enzyme immunoassay for carcinoembryonic antigen (CEA) with homogeneous reactivity to different CEA preparations and low crossreactivity with CEArelated normal antigens. J Immunol Methods 1993; 162: 235-245.
16. Chan DW, editor. Immunoassay automation. An updated guide to systems. San Diego: Academic Press, 1996.
17. Patterson W, Werness P, Payne WJ, Matsson P, Leflar C, Melander T, et ah Random and continuousaccess immunoassays with chemiluminescent detection by Access automated analyzer. Clin Chem 1994; 40: 2042-045.
18. Matsuoka Y, Matsuo Y, Okamoto N, Kuroki M, Ikehara Y. Highly effective extraction of carcinoembryonic antigen with phosphatidylinositolspecific phospholipase C. Tumor Biol 1991; 12: 91-98.
19. Kuroki M, Ichiki S, Matsuoka Y. Coproduction of carcinoembryonic antigen and nonspecific crossreacting antigen by a continuous cell line from a human pancreatic tumor. J Natl Cancer Inst 1982; 69: 401-408.
20. Matsuoka Y, Kuroki M, Koga Y, Kuriyama H, Mori T, Kosaki G. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces. Cancer Res 1982; 42: 2012-018.
21. Kuroki M, Koga Y, Matsuoka Y. Purification and characterization of carcinoembryonic antigenrelated antigens in normal adult feces. Cancer Res 1981; 41: 713-720.
22. Kuroki M, Shinoda T. Takayasu T, Koga Y, Matsuoka Y. Immunological characterization and structural studies of normal fecal antigen-1 related to carcinoembryonic antigen. Mol Immunol 1982; 19: 399-406.
23. Koga Y, Kuroki M, Matsunaga A, Shinoda T, Takayasu T, Matsuoka Y. Further comparative studies on chemical properties of carcinoembryonic antigen in tumor tissues and closely related antigens in adult feces and meconium. Mol Immunol 1985; 22: 67-73.
24. Staros JV, Wright RW, Swingle DM. Enhancement by Nhy-droxvsulfosuccinimide of watersoluble carbodiimidcmedi-ated coupling reactions. Anal Biochem 1986; 156: 220-222.
25. Hashida S, Imagawa M, Inoue S, Ruan KH, Ishikawa E. More useful maleimide compounds for the conjugation of Fab* to horseradish peroxidase through thiol groups in the hinge. J Appl Biochem 1984; 6: 56-63.
26. Yamashita K, Totani K, Iwaki Y, Kuroki M, Matsuoka Y, Endo T, Kobata A. Carbohydrate structures of nonspecific crossreacting antigen-2, a glycoprotein purified from meconium as an antigen crossreacting with anticarcinoembryonic antigen antibody. Occurrence of complextype sugar chains with the Galβl - 3GIcNAcβl - 3Gaiβl - 4GlcNAcβl - outer chains. J Biol Chem 1989; 264: 17873-7881.
27. Ichiki S, Kuroki M, Matsunaga A, Arajkawa F, Okamoto N, Matsuoka Y. Antigenic alterations of carcinoembryonic antigen involved in the secretion from various human tumor cell lines. Jpn J Cancer Res 1986; 77: 1005-1011.
28. van Dalen A, Kessler A-C. A multicentre evaluation of tumour marker determinations using the automatic Enzymuntest® systems ES 300 and ES 600/700. Eur J Clin Chem Clin Biochem 1996; 34: 377-384.
29. Conejo JR, Benedito JE, Jiménez A, Menchén MT, Cano J, Granizo V, Larrodera L. Diagnostic value of three tumour markers determined in pleural effusions. Eur J Clin Chem Clin Biochem 1996; 34: 139-142.
30. Stieber P, Dienemann H, Hasholzner U, Müller C, Poley S, Hofmann K, FatehMoghadam A. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer. Eur J Clin Chem Clin Biochem 1993; 31: 689-694.
31. Bauemfeind M, Wood WG. Evaluation of a fully mechanised immunoassay -Enzymuntest system ES 300 - and comparison with inhouse methods for 8 analytes. Eur J Clin Chem Clin Biochem 1993; 31: 165-172.
32. Kruse R, Geilenkeuser WJ, Röhle G. Interlaboratory surveys of the determination of tumour markers -scatter and repeatability of the results. Eur J Clin Chem Clin Biochem 1993; 31: 139-146.
33. Zucchelli GC, Pilo A, Jaworek D, Masini S, Chiesa MR. Immunoassay of CEA, CA 19-9, CA 125, and CA 15-3 on the automated systems ES 300 and ES 600: methodological evaluation from a multicentre collaborative study. Eur J Clin Chem Clin Biochem 1992; 30: 875-879.
34. Stieber P, Nagel D, Ritzke C, Rössler N, Kirsch CM, Eiermann W, FatehMoghadam A. Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma. Eur J Clin Chem Clin Biochem 1992; 30: 809-814.